Consensus XP Inc.

Stocks

XP

KYG982391099

Investment Banking & Brokerage Services

Real-time Estimate Cboe BZX Other stock markets 05:24:39 13/06/26 am AEST			5-day change	1st Jan Change
16.02 ^USD	+2.40%		+4.47%	-2.11%

27/05	Xp Inc. Announces Board Changes, Effective May 29, 2026	CI
20/05	Top Midday Decliners	MT

Evolution of the Average Target: XP Inc.

Evolution of the Target Price: XP Inc.

Changes in Analyst Recommendations: XP Inc.

67ca2dcca8e47be1a009e373a.OEAzE1ymhdYZSdDpdMpBEk_N3LDhFhLTzZcwf6EnAMQ.bS1FUQ3xyp10GqqORft1Jhu-juepfyHjgNNdSOUVVqhJE1lLHsvfo1gPhQ~5a6005884498dcf62b5eef0c64d1f5b6

Analysts' recommendations: XP Inc.

03/04	UBS Adjusts Price Target on XP to $28 From $25, Maintains Buy Rating	MT
21/01	Jefferies Initiates XP at Buy With $22 Price Target	MT
17/12	UBS Adjusts XP Price Target to $25 From $23, Maintains Buy Rating	MT
17/10/25	UBS Adjusts Price Target on XP to $23 From $24, Maintains Buy Rating	MT
24/06/25	XP Shares Drop After Downgrade From Itau BBA	MT
23/06/25	Itau BBA Downgrades XP to Market Perform From Outperform, Adjusts Price Target to $21 From $20	MT
10/06/25	UBS Adjusts XP Price Target to $24 From $17, Maintains Buy Rating	MT
04/06/25	Goldman Sachs Upgrades XP to Buy From Neutral, $23 Price Target	MT
14/05/25	XP Shares Rise After Morgan Stanley Upgrades to Overweight From Equalweight	MT
13/05/25	Morgan Stanley Upgrades XP to Overweight From Equalweight, Adjusts Price Target to $24 From $18	MT
08/04/25	UBS Adjusts Price Target on XP to $17 From $16, Keeps Buy Rating	MT
18/03/25	Itau BBA Initiates XP at Outperform With $20 Price Target	MT
25/01/25	XP Shares Rise After Upgrade From UBS	MT
25/01/25	UBS Upgrades XP to Buy From Neutral, Cuts Price Target to $16 From $19	MT
11/12/24	BofA Securities Downgrades XP to Neutral From Buy, Price Target is $16	MT
26/11/24	UBS Cuts Price Target on XP to $19 From $21, Maintains Neutral Rating	MT
11/07/24	UBS Downgrades XP to Neutral From Buy, Cuts Price Target to $21 From $30	MT
05/07/24	Bradesco BBI Downgrades XP to Neutral From Outperform, Cuts Price Target to $19 From $31	MT
06/06/24	Citigroup Adjusts Price Target on XP to $27 From $29, Maintains Buy Rating	MT
01/05/24	XP Shares Decline After Goldman Sachs Downgrade	MT
30/04/24	Goldman Sachs Downgrades XP to Neutral From Buy, Cuts Price Target to $23 From $30	MT
23/04/24	Morgan Stanley Downgrades XP to Equalweight From Overweight, Adjusts Price Target to $24 From $31	MT
23/03/24	Citigroup Adjusts Price Target on XP to $29 From $28, Maintains Buy Rating	MT
12/12/23	UBS Adjusts XP Price Target to $30 From $31, Maintains Buy Rating	MT
05/12/23	JPMorgan Upgrades XP to Overweight From Neutral, Raises Price Target to $30 From $27	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
XP INC.				+52.64%
GUOTAI HAITONG SECURITIES CO., LTD.				+33.45%
EAST MONEY INFORMATION CO.,LTD.				+59.37%
INTERACTIVE BROKERS GROUP, INC.				-0.63%
CHINA GALAXY SECURITIES CO., LTD.				+48.34%
ORIENT SECURITIES COMPANY LIMITED				+44.04%
ZHESHANG SECURITIES CO., LTD.		-	-	+47.12%
CHANGJIANG SECURITIES COMPANY LIMITED	-	-		+16.26%
Average				+37.57%
Weighted average by Cap.				+34.57%